FARRAGUT PARTNERS LLP for ASTRAZENECA PHARMACEUTICALS LP
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 20, 2017 | $30,000 | Replaced |
| 2nd Quarter - Amendment | Oct 19, 2017 | $40,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Medicare Part B and FDA. Cancer Payment Reform Legislation S. 462. Issues related to the 340B Drug discount program
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFF MACKINNON | Prof Staff on E&C Cmte and LA Rep Whitfield |
| JEFFERY C. MORTIER | LD & LA Rep. Joe Barton (RTexas) |
| J DANIEL WALSH | LD Rep. Wayne Gilchrest and LA Rep. Jack Buechner |
| SARAH WALTER | Former Legislative Director/Chief Counsel, Sen. John Breaux |
Medicare/Medicaid MMM
Medicare Part B and FDA. Cancer Payment Reform Legislation S. 462. Issues related to the 340B Drug discount program
| Lobbyist | Covered position, as disclosed |
|---|---|
| JODY SHINTARO GALE | — |
| JEFF MACKINNON | LD & LA Rep. Joe Barton (RTexas) |
| JEFFERY C. MORTIER | Prof Staff on E&C Cmte and LA Rep Whitfield |
| JOSEPH V VASAPOLI | Min. Counsel, Energy&Comm, Special Asst. DOE |
| J DANIEL WALSH | LD Rep. Wayne Gilchrest and LA Rep. Jack Buechner |
| SARAH WALTER | Former Legislative Director/Chief Counsel, Sen. John Breaux |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.